Myotonic dystrophy types 1 (DM1) and 2 (DM2) are similar yet distinct autosomal-dominant disorders characterized by muscle weakness, myotonia, cataracts, and multiple organ involvement, including the brain. One key difference between DM1 and DM2 is that a congenital form has been described for DM1 only. Expression of RNA transcripts containing pathogenic repeat lengths produces defects in alternative splicing of multiple RNAs, sequesters specific repeat-binding proteins, and ultimately leads to developmentally inappropriate splice products for a particular tissue. Whether brain pathology in its entirety in adult DM1 and DM2 is caused by interference in RNA processing remains to be determined. This review focuses on the similarities and differences between DM1 and DM2 with respect to neuropsychological, neuropathological, and neuroimaging data relating to cerebral involvement, with special emphasis on the clinical relevance and social consequences of such involvement.

Cerebral involvement in myotonic dystrophies / G. Meola, V. Sansone. - In: MUSCLE & NERVE. - ISSN 0148-639X. - 36:3(2007), pp. 294-306. [10.1002/mus.20800]

Cerebral involvement in myotonic dystrophies

G. Meola;V. Sansone
2007

Abstract

Myotonic dystrophy types 1 (DM1) and 2 (DM2) are similar yet distinct autosomal-dominant disorders characterized by muscle weakness, myotonia, cataracts, and multiple organ involvement, including the brain. One key difference between DM1 and DM2 is that a congenital form has been described for DM1 only. Expression of RNA transcripts containing pathogenic repeat lengths produces defects in alternative splicing of multiple RNAs, sequesters specific repeat-binding proteins, and ultimately leads to developmentally inappropriate splice products for a particular tissue. Whether brain pathology in its entirety in adult DM1 and DM2 is caused by interference in RNA processing remains to be determined. This review focuses on the similarities and differences between DM1 and DM2 with respect to neuropsychological, neuropathological, and neuroimaging data relating to cerebral involvement, with special emphasis on the clinical relevance and social consequences of such involvement.
brain ; myotonic dystrophy type 1 ; myotonic dystrophy type 2 ; neuroimaging ; neuropsychological tests
Settore MED/26 - Neurologia
2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
MUSCLE&NERVE 2007-Meola-Sansone.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 136.93 kB
Formato Adobe PDF
136.93 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/39153
Citazioni
  • ???jsp.display-item.citation.pmc??? 77
  • Scopus 200
  • ???jsp.display-item.citation.isi??? 180
social impact